{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:40:24Z","timestamp":1787992824872,"version":"build-2784847793"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Agency, Poland","award":["2019\/ABM\/01\/00037"],"award-info":[{"award-number":["2019\/ABM\/01\/00037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The epidemic of diabetes mellitus (DM) necessitates the development of novel therapeutic and preventative strategies to attenuate complications of this debilitating disease. Diabetic cardiomyopathy (DCM) is a frequent disorder affecting individuals diagnosed with DM characterized by left ventricular hypertrophy, diastolic and systolic dysfunction and myocardial fibrosis in the absence of other heart diseases. Progression of DCM is associated with impaired cardiac insulin metabolic signaling, increased oxidative stress, impaired mitochondrial and cardiomyocyte calcium metabolism, and inflammation. Various non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), as well as their target genes are implicated in the complex pathophysiology of DCM. It has been demonstrated that miRNAs and lncRNAs play an important role in maintaining homeostasis through regulation of multiple genes, thus they attract substantial scientific interest as biomarkers for diagnosis, prognosis and as a potential therapeutic strategy in DM complications. This article will review the different miRNAs and lncRNA studied in the context of DM, including type 1 and type 2 diabetes and the contribution of pathophysiological mechanisms including inflammatory response, oxidative stress, apoptosis, hypertrophy and fibrosis to the development of DCM .<\/jats:p>","DOI":"10.1186\/s12933-021-01245-2","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:04:07Z","timestamp":1614420247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics"],"prefix":"10.1186","volume":"20","author":[{"given":"Daniel","family":"Jakubik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Fitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-9625","authenticated-orcid":false,"given":"Ceren","family":"Eyileten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jarosz-Popek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Czajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Wicik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Postula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"1245_CR1","unstructured":"Website. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. https:\/\/www.diabetesatlas.org"},{"key":"1245_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010009","author":"J Jarosz-Popek","year":"2020","unstructured":"Jarosz-Popek J, Wolska M, Gasecka A, Czajka P, Jakubik D, Sharif L, et al. The importance of non-coding RNAs in neurodegenerative processes of diabetes-related molecular pathways. J Clin Med Res. 2020. https:\/\/doi.org\/10.3390\/jcm10010009.","journal-title":"J Clin Med Res."},{"issue":"Suppl","key":"1245_CR3","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8-16. https:\/\/doi.org\/10.2337\/dc15-S005.","journal-title":"Diabetes Care"},{"key":"1245_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01514","author":"G Borghetti","year":"2018","unstructured":"Borghetti G, von Lewinski D, Eaton DM, Sourij H, Houser SR, Wallner M. Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control. Front Physiol. 2018. https:\/\/doi.org\/10.3389\/fphys.2018.01514.","journal-title":"Front Physiol"},{"key":"1245_CR5","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.241.19.2035","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035\u20138. https:\/\/doi.org\/10.1001\/jama.241.19.2035.","journal-title":"JAMA"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circresaha.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122:624\u201338. https:\/\/doi.org\/10.1161\/circresaha.117.311586.","journal-title":"Circ Res"},{"key":"1245_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0939-5","author":"T Pant","year":"2018","unstructured":"Pant T, Dhanasekaran A, Fang J, Bai X, Bosnjak ZJ, Liang M, et al. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord. 2018. https:\/\/doi.org\/10.1186\/s12872-018-0939-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"1245_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2019.02.003","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, De Martino F, et al. Diabetic cardiomyopathy. Heart Fail Clin. 2019. https:\/\/doi.org\/10.1016\/j.hfc.2019.02.003.","journal-title":"Heart Fail Clin"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/heartjnl-2016-310342","volume":"105","author":"MMY Lee","year":"2019","unstructured":"Lee MMY, McMurray JJV, Lorenzo-Almor\u00f3s A, Kristensen SL, Sattar N, Jhund PS, et al. Diabetic cardiomyopathy. Heart. 2019;105:337\u201345. https:\/\/doi.org\/10.1136\/heartjnl-2016-310342.","journal-title":"Heart"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586.","journal-title":"Circ Res"},{"issue":"1718\u201327","key":"1245_CR11","doi-asserted-by":"publisher","first-page":"1727a","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovi\u0107","year":"2015","unstructured":"Seferovi\u0107 PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36(1718\u201327):1727a\u20131727c. https:\/\/doi.org\/10.1093\/eurheartj\/ehv134.","journal-title":"Eur Heart J"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","volume":"62","author":"G Murtaza","year":"2019","unstructured":"Murtaza G, Virk HUH, Khalid M, Lavie CJ, Ventura H, Mukherjee D, et al. Diabetic cardiomyopathy\u2014a comprehensive updated review. Prog Cardiovasc Dis. 2019;62:315\u201326. https:\/\/doi.org\/10.1016\/j.pcad.2019.03.003.","journal-title":"Prog Cardiovasc Dis"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019;140:e294-324. https:\/\/doi.org\/10.1161\/CIR.0000000000000691.","journal-title":"Circulation"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607. https:\/\/doi.org\/10.1038\/s41569-020-0339-2.","journal-title":"Nat Rev Cardiol"},{"key":"1245_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0506-x","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s A, Tu\u00f1\u00f3n J, Orejas M, Cort\u00e9s M, Egido J, Lorenzo \u00d3. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017. https:\/\/doi.org\/10.1186\/s12933-017-0506-x.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR16","doi-asserted-by":"publisher","DOI":"10.1042\/cs20160491","author":"M Tate","year":"2017","unstructured":"Tate M, Grieve DJ, Ritchie RH. Are targeted therapies for diabetic cardiomyopathy on the horizon? Clin Sci. 2017. https:\/\/doi.org\/10.1042\/cs20160491.","journal-title":"Clin Sci"},{"key":"1245_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8549-4_5","author":"DR Germolec","year":"2018","unstructured":"Germolec DR, Shipkowski KA, Frawley RP, Evans E. Markers of Inflammation. Methods Mol Biol. 2018. https:\/\/doi.org\/10.1007\/978-1-4939-8549-4_5.","journal-title":"Methods Mol Biol"},{"key":"1245_CR18","doi-asserted-by":"publisher","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14:50\u20139. https:\/\/doi.org\/10.15420\/ecr.2018.33.1","DOI":"10.15420\/ecr.2018.33.1"},{"key":"1245_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1766670","author":"BS Biesinger","year":"2020","unstructured":"Biesinger BS, Gasecka A, Perkmann T, Wojta J, Lesiak M, Grygier M, et al. Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS. Platelets. 2020. https:\/\/doi.org\/10.1080\/09537104.2020.1766670.","journal-title":"Platelets"},{"key":"1245_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.vph.2017.06.002","volume":"93\u201395","author":"A Komosa","year":"2017","unstructured":"Komosa A, Rzymski P, Perek B, Ropacka-Lesiak M, Lesiak M, Siller-Matula JM, et al. Platelets redox balance assessment: current evidence and methodological considerations. Vasc Pharmacol. 2017;93\u201395:6\u201313. https:\/\/doi.org\/10.1016\/j.vph.2017.06.002.","journal-title":"Vasc Pharmacol"},{"key":"1245_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091364","author":"A Komosa","year":"2019","unstructured":"Komosa A, Perek B, Rzymski P, Lesiak M, Siller-Matula JM, Grygier M, et al. Transcatheter aortic valve replacement is associated with less oxidative stress and faster recovery of antioxidant capacity than surgical aortic valve replacement. J Clin Med Res. 2019. https:\/\/doi.org\/10.3390\/jcm8091364.","journal-title":"J Clin Med Res"},{"key":"1245_CR22","doi-asserted-by":"publisher","DOI":"10.2174\/157016110790887009","author":"S Rosa","year":"2010","unstructured":"Rosa S, Cirillo P, Paglia A, Sasso L, Palma V, Chiariello M. Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol. 2010. https:\/\/doi.org\/10.2174\/157016110790887009.","journal-title":"Curr Vasc Pharmacol"},{"key":"1245_CR23","doi-asserted-by":"publisher","unstructured":"Burgos-Mor\u00f3n, Burgos-Mor\u00f3n, Abad-Jim\u00e9nez, Mara\u00f1\u00f3n, Iannantuoni, Escribano-L\u00f3pez, et al. Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8091385","DOI":"10.3390\/jcm8091385"},{"key":"1245_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fendo.2018.00002","volume":"9","author":"S De Rosa","year":"2018","unstructured":"De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol. 2018;9:2. https:\/\/doi.org\/10.3389\/fendo.2018.00002.","journal-title":"Front Endocrinol"},{"key":"1245_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0918-x","author":"J Pordzik","year":"2019","unstructured":"Pordzik J, Jakubik D, Jarosz-Popek J, Wicik Z, Eyileten C, De Rosa S, et al. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovasc Diabetol. 2019. https:\/\/doi.org\/10.1186\/s12933-019-0918-x.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-02101-2","author":"C Eyileten","year":"2020","unstructured":"Eyileten C, Sharif L, Wicik Z, Jakubik D, Jarosz-Popek J, Soplinska A, et al. The relation of the brain-derived neurotrophic factor with MicroRNAs in neurodegenerative diseases and ischemic stroke. Mol Neurobiol. 2020. https:\/\/doi.org\/10.1007\/s12035-020-02101-2.","journal-title":"Mol Neurobiol"},{"key":"1245_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2019.07.001","volume":"134","author":"J Sabatino","year":"2019","unstructured":"Sabatino J, Wicik Z, De Rosa S, Eyileten C, Jakubik D, Spaccarotella C, et al. MicroRNAs fingerprint of bicuspid aortic valve. J Mol Cell Cardiol. 2019;134:98\u2013106. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.07.001.","journal-title":"J Mol Cell Cardiol"},{"key":"1245_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.01.011","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018. https:\/\/doi.org\/10.1016\/j.cell.2018.01.011.","journal-title":"Cell"},{"key":"1245_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110228","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Shoorei H, Taheri M. Non-coding RNAs are involved in the response to oxidative stress. Biomed Pharmacother. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2020.110228.","journal-title":"Biomed Pharmacother"},{"key":"1245_CR30","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.14-260323","volume":"29","author":"JL Marques-Rocha","year":"2015","unstructured":"Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Mart\u00ednez JA, Marti A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015;29:3595\u2013611. https:\/\/doi.org\/10.1096\/fj.14-260323.","journal-title":"FASEB J"},{"key":"1245_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trsl.2019.08.007","volume":"215","author":"M Calderon-Dominguez","year":"2020","unstructured":"Calderon-Dominguez M, Belmonte T, Quezada-Feijoo M, Ramos-S\u00e1nchez M, Fern\u00e1ndez-Armenta J, P\u00e9rez-Navarro A, et al. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology. Transl Res. 2020;215:86\u2013101. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.007.","journal-title":"Transl Res"},{"key":"1245_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/2211536607666180402120806","volume":"7","author":"JG Hijmans","year":"2018","unstructured":"Hijmans JG, Diehl KJ, Bammert TD, Kavlich PJ, Lincenberg GM, Greiner JJ, et al. Influence of overweight and obesity on circulating inflammation-related microRNA. Microrna. 2018;7:148\u201354. https:\/\/doi.org\/10.2174\/2211536607666180402120806.","journal-title":"Microrna"},{"key":"1245_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01107-3","author":"K Ait-Aissa","year":"2020","unstructured":"Ait-Aissa K, Nguyen QM, Gabani M, Kassan A, Kumar S, Choi S-K, et al. MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy. Cardiovasc Diabetol. 2020. https:\/\/doi.org\/10.1186\/s12933-020-01107-3.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2015.06.003","author":"M Yu","year":"2015","unstructured":"Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Cardiovasc Pathol. 2015. https:\/\/doi.org\/10.1016\/j.carpath.2015.06.003.","journal-title":"Cardiovasc Pathol"},{"key":"1245_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c160021","author":"X Hu","year":"2017","unstructured":"Hu X, Bai T, Xu Z, Liu Q, Zheng Y, Cai L. Pathophysiological fundamentals of diabetic cardiomyopathy. Comprehensive Physiol. 2017. https:\/\/doi.org\/10.1002\/cphy.c160021.","journal-title":"Comprehensive Physiol"},{"key":"1245_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133264","author":"I Evangelista","year":"2019","unstructured":"Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A. Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133264.","journal-title":"Int J Mol Sci"},{"key":"1245_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.07.019","author":"L Gao","year":"2018","unstructured":"Gao L, Liu Y, Guo S, Xiao L, Wu L, Wang Z, et al. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21\/PPARa signaling. Biochimica et Biophysica Acta (BBA) Mol Basis Dis. 2018. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.019.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Dis."},{"key":"1245_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.430","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q, Li J, Chen X, Liu X, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014. https:\/\/doi.org\/10.1038\/cddis.2014.430.","journal-title":"Cell Death Dis"},{"key":"1245_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9679-4","author":"V Chavali","year":"2014","unstructured":"Chavali V, Tyagi SC, Mishra PK. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2 \/\u2212 Akita hearts. Cell Biochem Biophys. 2014. https:\/\/doi.org\/10.1007\/s12013-013-9679-4.","journal-title":"Cell Biochem Biophys"},{"key":"1245_CR40","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.3892\/mmr.2019.10057","volume":"19","author":"T Wang","year":"2019","unstructured":"Wang T, Zhu H, Yang S, Fei X. Let-7a-5p may participate in the pathogenesis of diabetic nephropathy through targeting HMGA2. Mol Med Rep. 2019;19:4229\u201337. https:\/\/doi.org\/10.3892\/mmr.2019.10057.","journal-title":"Mol Med Rep"},{"key":"1245_CR41","doi-asserted-by":"publisher","first-page":"e89656","DOI":"10.1172\/jci.insight.89656","volume":"2","author":"S Erener","year":"2017","unstructured":"Erener S, Marwaha A, Tan R, Panagiotopoulos C, Kieffer TJ. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight. 2017;2:e89656. https:\/\/doi.org\/10.1172\/jci.insight.89656.","journal-title":"JCI Insight"},{"key":"1245_CR42","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.7150\/thno.15007","volume":"6","author":"L Tao","year":"2016","unstructured":"Tao L, Bei Y, Chen P, Lei Z, Fu S, Zhang H, et al. Crucial role of miR-433 in regulating cardiac fibrosis. Theranostics. 2016;6:2068\u201383. https:\/\/doi.org\/10.7150\/thno.15007.","journal-title":"Theranostics"},{"key":"1245_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajpath.2011.04.034","volume":"179","author":"E Shen","year":"2011","unstructured":"Shen E, Diao X, Wang X, Chen R, Hu B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol. 2011;179:639\u201350. https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.034.","journal-title":"Am J Pathol"},{"key":"1245_CR44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, L\u00fcscher TF, Cosentino F. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J. 2016;37:572\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehv599.","journal-title":"Eur Heart J"},{"key":"1245_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9672-y","author":"SS Yildirim","year":"2013","unstructured":"Yildirim SS, Akman D, Catalucci D, Turan B. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: Junctin as a target protein of miR-1. Cell Biochem Biophys. 2013. https:\/\/doi.org\/10.1007\/s12013-013-9672-y.","journal-title":"Cell Biochem Biophys"},{"key":"1245_CR46","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/db11-0952","volume":"61","author":"S Greco","year":"2012","unstructured":"Greco S, Fasanaro P, Castelvecchio S, D\u2019Alessandra Y, Arcelli D, Di Donato M, et al. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes. 2012;61:1633\u201341. https:\/\/doi.org\/10.2337\/db11-0952.","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"1245_CR47","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0168-8227(09)70002-6","volume":"86","author":"A Ceriello","year":"2009","unstructured":"Ceriello A. Hypothesis: the \u201cmetabolic memory\u201d, the new challenge of diabetes. Diabetes Res Clin Pract. 2009;86(Suppl 1):S2-6. https:\/\/doi.org\/10.1016\/S0168-8227(09)70002-6.","journal-title":"Diabetes Res Clin Pract"},{"key":"1245_CR48","doi-asserted-by":"publisher","DOI":"10.2741\/2692","author":"FO Martinez","year":"2008","unstructured":"Martinez FO. Macrophage activation and polarization. Front Biosci. 2008. https:\/\/doi.org\/10.2741\/2692.","journal-title":"Front Biosci"},{"key":"1245_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.267443","author":"MF Corsten","year":"2012","unstructured":"Corsten MF, Papageorgiou A, Verhesen W, Carai P, Lindow M, Obad S, et al. MicroRNA profiling identifies MicroRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res. 2012. https:\/\/doi.org\/10.1161\/circresaha.112.267443.","journal-title":"Circ Res"},{"key":"1245_CR50","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s138400","author":"C Jia","year":"2017","unstructured":"Jia C, Chen H, Wei M, Chen X, Zhang Y, Cao L, et al. Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model. Int J Nanomed. 2017. https:\/\/doi.org\/10.2147\/ijn.s138400.","journal-title":"Int J Nanomed"},{"key":"1245_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep36207","author":"SS Babu","year":"2016","unstructured":"Babu SS, Thandavarayan RA, Joladarashi D, Jeyabal P, Krishnamurthy S, Bhimaraj A, et al. MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep36207.","journal-title":"Sci Rep"},{"key":"1245_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/gad.1039703","volume":"17","author":"DF Seals","year":"2003","unstructured":"Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003;17:7\u201330. https:\/\/doi.org\/10.1101\/gad.1039703.","journal-title":"Genes Dev"},{"key":"1245_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transducti Target Therapy. 2017. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transducti Target Therapy"},{"key":"1245_CR54","doi-asserted-by":"publisher","first-page":"e19724","DOI":"10.1371\/journal.pone.0019724","volume":"6","author":"X Palomer","year":"2011","unstructured":"Palomer X, \u00c1lvarez-Guardia D, Davidson MM, Chan TO, Feldman AM, V\u00e1zquez-Carrera M. The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells. PLoS ONE. 2011;6:e19724. https:\/\/doi.org\/10.1371\/journal.pone.0019724.","journal-title":"PLoS ONE"},{"key":"1245_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/1947601910373795","volume":"1","author":"K Lin","year":"2010","unstructured":"Lin K, Baritaki S, Militello L, Malaponte G, Bevelacqua Y, Bonavida B. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-\u03baB\/Snail\/RKIP\/PTEN circuit. Genes Cancer. 2010;1:409\u201320. https:\/\/doi.org\/10.1177\/1947601910373795.","journal-title":"Genes Cancer"},{"key":"1245_CR56","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14:1483\u201396. https:\/\/doi.org\/10.7150\/ijbs.27173.","journal-title":"Int J Biol Sci"},{"key":"1245_CR57","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.120.15016","volume":"76","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lv H, Tan R, An X, Niu X-H, Liu Y-J, et al. Platelets promote Ang II (Angiotensin II)-induced atrial fibrillation by releasing TGF-\u03b21 (transforming growth factor-\u03b21) and interacting with fibroblasts. Hypertension. 2020;76:1856\u201367. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15016.","journal-title":"Hypertension"},{"key":"1245_CR58","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1182\/blood-2011-09-377648","volume":"119","author":"A Meyer","year":"2012","unstructured":"Meyer A, Wang W, Qu J, Croft L, Degen JL, Coller BS, et al. Platelet TGF-\u03b21 contributions to plasma TGF-\u03b21, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood. 2012;119:1064\u201374. https:\/\/doi.org\/10.1182\/blood-2011-09-377648.","journal-title":"Blood"},{"key":"1245_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.143995","author":"X Yang","year":"2019","unstructured":"Yang X, Li X, Lin Q, Xu Q. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA. Gene. 2019. https:\/\/doi.org\/10.1016\/j.gene.2019.143995.","journal-title":"Gene"},{"key":"1245_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29386","author":"H Che","year":"2019","unstructured":"Che H, Wang Y, Li Y, Lv J, Li H, Liu Y, et al. Inhibition of microRNA-150\u20135p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. J Cell Physiol. 2019. https:\/\/doi.org\/10.1002\/jcp.29386.","journal-title":"J Cell Physiol."},{"key":"1245_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.171","author":"C Freudlsperger","year":"2013","unstructured":"Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, et al. TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013. https:\/\/doi.org\/10.1038\/onc.2012.171.","journal-title":"Oncogene"},{"key":"1245_CR62","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.celrep.2017.08.060","volume":"20","author":"Z Chen","year":"2017","unstructured":"Chen Z, Stelekati E, Kurachi M, Yu S, Cai Z, Manne S, et al. miR-150 regulates memory CD8 T cell differentiation via c-Myb. Cell Rep. 2017;20:2584\u201397. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.060.","journal-title":"Cell Rep"},{"key":"1245_CR63","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.biopha.2018.11.058","volume":"109","author":"Y Li","year":"2019","unstructured":"Li Y, Ren W, Wang X, Yu X, Cui L, Li X, et al. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension. Biomed Pharmacother. 2019;109:1740\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.058.","journal-title":"Biomed Pharmacother"},{"key":"1245_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2015.11.001","volume":"172","author":"W Sang","year":"2016","unstructured":"Sang W, Wang Y, Zhang C, Zhang D, Sun C, Niu M, et al. MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28\/B7 costimulatory pathway. Immunol Lett. 2016;172:1\u201310. https:\/\/doi.org\/10.1016\/j.imlet.2015.11.001.","journal-title":"Immunol Lett"},{"key":"1245_CR65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/abbs\/gmt067","volume":"45","author":"X Li","year":"2013","unstructured":"Li X, Kong M, Jiang D, Qian J, Duan Q, Dong A. MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene. Acta Biochim Biophys Sin. 2013;45:734\u201341. https:\/\/doi.org\/10.1093\/abbs\/gmt067.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1245_CR66","first-page":"1208","volume":"11","author":"G-H Zhu","year":"2018","unstructured":"Zhu G-H, Li R, Zeng Y, Zhou T, Xiong F, Zhu M. MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-\u03b21\/Smad pathway in primary human aortic endothelial cells. Int J Clin Exp Pathol. 2018;11:1208\u201317.","journal-title":"Int J Clin Exp Pathol"},{"key":"1245_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jcjd.2013.07.003","volume":"37","author":"MA Ruiz","year":"2013","unstructured":"Ruiz MA, Chakrabarti S. MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes. Can J Diabetes. 2013;37:339\u201344. https:\/\/doi.org\/10.1016\/j.jcjd.2013.07.003.","journal-title":"Can J Diabetes"},{"key":"1245_CR68","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/mmr.2011.489","volume":"4","author":"X Diao","year":"2011","unstructured":"Diao X, Shen E, Wang X, Hu B. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice. Mol Med Rep. 2011;4:633\u201340. https:\/\/doi.org\/10.3892\/mmr.2011.489.","journal-title":"Mol Med Rep"},{"key":"1245_CR69","doi-asserted-by":"publisher","DOI":"10.4149\/endo_2014_02_103","author":"SS Emadi","year":"2014","unstructured":"Emadi SS, Soufi FG, Khamaneh AM, Alipour MR. MicroRNA-146a expression and its intervention in NF-\u043aB signaling pathway in diabetic rat aorta. Endoc Regul. 2014. https:\/\/doi.org\/10.4149\/endo_2014_02_103.","journal-title":"Endoc Regul"},{"key":"1245_CR70","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13076","author":"Q Wang","year":"2014","unstructured":"Wang Q, Bozack SN, Yan Y, Boulton ME, Grant MB, Busik JV. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina. Investig Opthalmol Vis Sci. 2014. https:\/\/doi.org\/10.1167\/iovs.13-13076.","journal-title":"Investig Opthalmol Vis Sci"},{"key":"1245_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2017.03.002","author":"B Feng","year":"2017","unstructured":"Feng B, Chen S, Gordon AD, Chakrabarti S. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes. J Mol Cell Cardiol. 2017. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.03.002.","journal-title":"J Mol Cell Cardiol"},{"key":"1245_CR72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1242\/dmm.020768","volume":"8","author":"X Palomer","year":"2015","unstructured":"Palomer X, Capdevila-Busquets E, Botteri G, Davidson MM, Rodr\u00edguez C, Mart\u00ednez-Gonz\u00e1lez J, et al. miR-146a targets Fos expression in human cardiac cells. Dis Model Mech. 2015;8:1081\u201391. https:\/\/doi.org\/10.1242\/dmm.020768.","journal-title":"Dis Model Mech"},{"key":"1245_CR73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ejhf.244","volume":"17","author":"CJ Watson","year":"2015","unstructured":"Watson CJ, Gupta SK, O\u2019Connell E, Thum S, Glezeva N, Fendrich J, et al. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail. 2015;17:405\u201315. https:\/\/doi.org\/10.1002\/ejhf.244.","journal-title":"Eur J Heart Fail"},{"key":"1245_CR74","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.ijcard.2012.06.006","volume":"167","author":"X Palomer","year":"2013","unstructured":"Palomer X, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pall\u00e0s M, Camins A, et al. Resveratrol induces nuclear factor-\u03baB activity in human cardiac cells. Int J Cardiol. 2013;167:2507\u201316. https:\/\/doi.org\/10.1016\/j.ijcard.2012.06.006.","journal-title":"Int J Cardiol"},{"key":"1245_CR75","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X, Salvad\u00f3 L, Barroso E, V\u00e1zquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol. 2013;168:3160\u201372. https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.150.","journal-title":"Int J Cardiol"},{"key":"1245_CR76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-011-0727-3","volume":"351","author":"M Balasubramanyam","year":"2011","unstructured":"Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem. 2011;351:197\u2013205. https:\/\/doi.org\/10.1007\/s11010-011-0727-3.","journal-title":"Mol Cell Biochem"},{"key":"1245_CR77","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2014.09.033","volume":"237","author":"S Li","year":"2014","unstructured":"Li S, Chen H, Ren J, Geng Q, Song J, Lee C, et al. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells. Atherosclerosis. 2014;237:514\u201320. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.033.","journal-title":"Atherosclerosis"},{"key":"1245_CR78","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nature06607","volume":"451","author":"JB Johnnidis","year":"2008","unstructured":"Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451:1125\u20139. https:\/\/doi.org\/10.1038\/nature06607.","journal-title":"Nature"},{"key":"1245_CR79","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/cvr\/cvq010","volume":"86","author":"H Lu","year":"2010","unstructured":"Lu H, Buchan RJ, Cook SA. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res. 2010;86:410\u201320. https:\/\/doi.org\/10.1093\/cvr\/cvq010.","journal-title":"Cardiovasc Res"},{"key":"1245_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0811-7","author":"Z Yin","year":"2019","unstructured":"Yin Z, Zhao Y, He M, Li H, Fan J, Nie X, et al. MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1. Cardiovasc Diabetol. 2019. https:\/\/doi.org\/10.1186\/s12933-019-0811-7.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00382","author":"RM da Costa","year":"2019","unstructured":"da Costa RM, da Costa RM, Rodrigues D, Pereira CA, Silva JF, Alves JV, et al. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.00382.","journal-title":"Front Pharmacol"},{"key":"1245_CR82","doi-asserted-by":"publisher","DOI":"10.1172\/jci88894","author":"V Dubois","year":"2017","unstructured":"Dubois V, Eeckhoute J, Lefebvre P, Staels B. Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Investig. 2017. https:\/\/doi.org\/10.1172\/jci88894.","journal-title":"J Clin Investig"},{"key":"1245_CR83","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0457ED","author":"RC Reddy","year":"2010","unstructured":"Reddy RC, Standiford TJ. Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. Am J Respir Crit Care Med. 2010. https:\/\/doi.org\/10.1164\/rccm.201004-0457ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"1245_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/641087","author":"S Polvani","year":"2012","unstructured":"Polvani S, Tarocchi M, Galli A. PPAR and oxidative stress: Con() catenating NRF2 and FOXO. PPAR Res. 2012. https:\/\/doi.org\/10.1155\/2012\/641087.","journal-title":"PPAR Res"},{"key":"1245_CR85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2017.06.002","volume":"110","author":"D Li","year":"2017","unstructured":"Li D, Du Y, Yuan X, Han X, Dong Z, Chen X, et al. Hepatic hypoxia-inducible factors inhibit PPAR\u03b1 expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity. Free Radic Biol Med. 2017;110:102\u201316. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.06.002.","journal-title":"Free Radic Biol Med"},{"key":"1245_CR86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1755-5922.12113","volume":"33","author":"SK Raut","year":"2015","unstructured":"Raut SK, Kumar A, Singh GB, Nahar U, Sharma V, Mittal A, et al. miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy. Cardiovasc Ther. 2015;33:89\u201397. https:\/\/doi.org\/10.1111\/1755-5922.12113.","journal-title":"Cardiovasc Ther"},{"key":"1245_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","volume":"417","author":"SK Raut","year":"2016","unstructured":"Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N, et al. miR-30c and miR-181a synergistically modulate p53\u2013p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem. 2016;417:191\u2013203. https:\/\/doi.org\/10.1007\/s11010-016-2729-7.","journal-title":"Mol Cell Biochem"},{"key":"1245_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.omtn.2017.03.005","volume":"7","author":"C Chen","year":"2017","unstructured":"Chen C, Yang S, Li H, Yin Z, Fan J, Zhao Y, et al. Mir30c is involved in diabetic cardiomyopathy through regulation of cardiac autophagy via BECN1. Mol Ther Nucleic Acids. 2017;7:127\u201339. https:\/\/doi.org\/10.1016\/j.omtn.2017.03.005.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1245_CR89","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1101\/gad.1998010","volume":"24","author":"GD Barish","year":"2010","unstructured":"Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, Benner C, et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 2010;24:2760\u20135. https:\/\/doi.org\/10.1101\/gad.1998010.","journal-title":"Genes Dev"},{"key":"1245_CR90","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ejhf.1119","volume":"20","author":"S De Rosa","year":"2018","unstructured":"De Rosa S, Eposito F, Carella C, Strangio A, Ammirati G, Sabatino J, et al. Transcoronary concentration gradients of circulating microRNAs in heart failure. Eur J Heart Fail. 2018;20:1000\u201310. https:\/\/doi.org\/10.1002\/ejhf.1119.","journal-title":"Eur J Heart Fail"},{"key":"1245_CR91","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1096\/fj.201901838R","volume":"34","author":"L Tao","year":"2020","unstructured":"Tao L, Huang X, Xu M, Yang L, Hua F. MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis. FASEB J. 2020;34:2173\u201397. https:\/\/doi.org\/10.1096\/fj.201901838R.","journal-title":"FASEB J"},{"key":"1245_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.12.013","author":"L Wang","year":"2017","unstructured":"Wang L, Wang M, Hu J, Shen W, Hu J, Yao Y, et al. Protective effect of 3H\u20131, 2-dithiole-3-thione on cellular model of Alzheimer\u2019s disease involves Nrf2\/ARE signaling pathway. Eur J Pharmacol. 2017. https:\/\/doi.org\/10.1016\/j.ejphar.2016.12.013.","journal-title":"Eur J Pharmacol"},{"key":"1245_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9167450","author":"Y Miao","year":"2017","unstructured":"Miao Y, Wan Q, Liu X, Wang Y, Luo Y, Liu D, et al. miR-503 is involved in the protective effect of phase II enzyme inducer (CPDT) in diabetic cardiomyopathy via Nrf2\/ARE signaling pathway. Biomed Res Int. 2017. https:\/\/doi.org\/10.1155\/2017\/9167450.","journal-title":"Biomed Res Int"},{"key":"1245_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12318","author":"Q Tang","year":"2018","unstructured":"Tang Q, Len Q, Liu Z, Wang W. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Cardiovasc Ther. 2018. https:\/\/doi.org\/10.1111\/1755-5922.12318.","journal-title":"Cardiovasc Ther"},{"key":"1245_CR95","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12877-019-1109-z","volume":"19","author":"C Mao","year":"2019","unstructured":"Mao C, Yuan J-Q, Lv Y-B, Gao X, Yin Z-X, Kraus VB, et al. Associations between superoxide dismutase, malondialdehyde and all-cause mortality in older adults: a community-based cohort study. BMC Geriatr. 2019;19:104. https:\/\/doi.org\/10.1186\/s12877-019-1109-z.","journal-title":"BMC Geriatr"},{"key":"1245_CR96","doi-asserted-by":"publisher","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","volume":"279","author":"VJ Thannickal","year":"2000","unstructured":"Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1005\u201328. https:\/\/doi.org\/10.1152\/ajplung.2000.279.6.L1005.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1245_CR97","doi-asserted-by":"publisher","first-page":"e00620","DOI":"10.1128\/mBio.00620-12","volume":"4","author":"BG Byrne","year":"2013","unstructured":"Byrne BG, Dubuisson J-F, Joshi AD, Persson JJ, Swanson MS. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. MBio. 2013;4:e00620-e712. https:\/\/doi.org\/10.1128\/mBio.00620-12.","journal-title":"MBio"},{"key":"1245_CR98","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","volume":"73","author":"SL Fink","year":"2005","unstructured":"Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73:1907\u201316. https:\/\/doi.org\/10.1128\/IAI.73.4.1907-1916.2005.","journal-title":"Infect Immun"},{"key":"1245_CR99","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jcb.20946","volume":"99","author":"Y-Q Zhang","year":"2006","unstructured":"Zhang Y-Q, Herman B. ARC protects rat cardiomyocytes against oxidative stress through inhibition of caspase-2 mediated mitochondrial pathway. J Cell Biochem. 2006;99:575\u201388. https:\/\/doi.org\/10.1002\/jcb.20946.","journal-title":"J Cell Biochem"},{"key":"1245_CR100","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00109-008-0434-z","volume":"87","author":"J An","year":"2009","unstructured":"An J, Li P, Li J, Dietz R, Donath S. ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity. J Mol Med. 2009;87:401\u201310. https:\/\/doi.org\/10.1007\/s00109-008-0434-z.","journal-title":"J Mol Med"},{"key":"1245_CR101","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.105.576785","volume":"113","author":"S Donath","year":"2006","unstructured":"Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V, Willnow T, et al. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation. 2006;113:1203\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.576785.","journal-title":"Circulation"},{"key":"1245_CR102","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.26355\/eurrev_202006_21533","volume":"24","author":"WY Zhang","year":"2020","unstructured":"Zhang WY, Wang J, Li AZ. A study of the effects of SGLT-2 inhibitors on diabetic cardiomyopathy through miR-30d\/KLF9\/VEGFA pathway. Eur Rev Med Pharmacol Sci. 2020;24:6346\u201359. https:\/\/doi.org\/10.26355\/eurrev_202006_21533.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"1245_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.02.065","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal P, Thandavarayan RA, Joladarashi D, Babu SS, Krishnamurthy S, Bhimaraj A, et al. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun. 2016. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.065.","journal-title":"Biochem Biophys Res Commun"},{"key":"1245_CR104","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3622-8","author":"D Zheng","year":"2015","unstructured":"Zheng D, Ma J, Yu Y, Li M, Ni R, Wang G, et al. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice. Diabetologia. 2015. https:\/\/doi.org\/10.1007\/s00125-015-3622-8.","journal-title":"Diabetologia"},{"key":"1245_CR105","doi-asserted-by":"publisher","DOI":"10.2174\/1574362410666141224210818","author":"L Xie","year":"2015","unstructured":"Xie L, Du R, Niu J, Liu H. Role of miRNAs in coronary artery disease. Curr Signal Transduct Ther. 2015. https:\/\/doi.org\/10.2174\/1574362410666141224210818.","journal-title":"Curr Signal Transduct Ther"},{"key":"1245_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305402","author":"SPR Romaine","year":"2015","unstructured":"Romaine SPR, Tomaszewski M, Condorelli G, Samani NJ. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart. 2015. https:\/\/doi.org\/10.1136\/heartjnl-2013-305402.","journal-title":"Heart"},{"key":"1245_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.30","author":"S-S Zhou","year":"2018","unstructured":"Zhou S-S, Jin J-P, Wang J-Q, Zhang Z-G, Freedman JH, Zheng Y, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018. https:\/\/doi.org\/10.1038\/aps.2018.30.","journal-title":"Acta Pharmacol Sin"},{"key":"1245_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030700","author":"B Kura","year":"2020","unstructured":"Kura B, Kalocayova B, Devaux Y, Bartekova M. Potential clinical implications of miR-1 and miR-21 in Heart disease and cardioprotection. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030700.","journal-title":"Int J Mol Sci."},{"key":"1245_CR109","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.yjmcc.2008.01.012","volume":"44","author":"C-S Hong","year":"2008","unstructured":"Hong C-S, Kwon S-J, Cho M-C, Kwak Y-G, Ha K-C, Hong B, et al. Overexpression of junctate induces cardiac hypertrophy and arrhythmia via altered calcium handling. J Mol Cell Cardiol. 2008;44:672\u201382. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.01.012.","journal-title":"J Mol Cell Cardiol"},{"key":"1245_CR110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ceca.2005.10.004","volume":"39","author":"U Kirchhefer","year":"2006","unstructured":"Kirchhefer U, Hanske G, Jones LR, Justus I, Kaestner L, Lipp P, et al. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling. Cell Calcium. 2006;39:131\u201342. https:\/\/doi.org\/10.1016\/j.ceca.2005.10.004.","journal-title":"Cell Calcium"},{"key":"1245_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.rcm.2020.01.577","volume":"21","author":"Z Song","year":"2020","unstructured":"Song Z, Gao R, Yan B. Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease. Rev Cardiovasc Med. 2020;21:57\u201364. https:\/\/doi.org\/10.31083\/j.rcm.2020.01.577.","journal-title":"Rev Cardiovasc Med."},{"key":"1245_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1054","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes\/Metab Res Rev. 2010. https:\/\/doi.org\/10.1002\/dmrr.1054.","journal-title":"Diabetes\/Metab Res Rev"},{"key":"1245_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12218","author":"S Chen","year":"2014","unstructured":"Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW, Chakrabarti S. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med. 2014. https:\/\/doi.org\/10.1111\/jcmm.12218.","journal-title":"J Cell Mol Med"},{"key":"1245_CR114","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/db16-0023","volume":"65","author":"SS Nandi","year":"2016","unstructured":"Nandi SS, Zheng H, Sharma NM, Shahshahan HR, Patel KP, Mishra PK. Lack of miR-133a decreases contractility of diabetic hearts: a role for novel cross talk between tyrosine aminotransferase and tyrosine hydroxylase. Diabetes. 2016;65:3075\u201390. https:\/\/doi.org\/10.2337\/db16-0023.","journal-title":"Diabetes"},{"key":"1245_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00045","author":"TN Kambis","year":"2019","unstructured":"Kambis TN, Shahshahan HR, Kar S, Yadav SK, Mishra PK. Transgenic expression of miR-133a in the diabetic akita heart prevents cardiac remodeling and cardiomyopathy. Front Cardiovasc Med. 2019. https:\/\/doi.org\/10.3389\/fcvm.2019.00045.","journal-title":"Front Cardiovasc Med"},{"key":"1245_CR116","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41598-017-00070-6","volume":"7","author":"D de Gonzalo-Calvo","year":"2017","unstructured":"de Gonzalo-Calvo D, van der Meer RW, Rijzewijk LJ, Smit JWA, Revuelta-Lopez E, Nasarre L, et al. Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes. Sci Rep. 2017;7:47. https:\/\/doi.org\/10.1038\/s41598-017-00070-6.","journal-title":"Sci Rep"},{"key":"1245_CR117","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/mt.2016.166","volume":"24","author":"D Ramanujam","year":"2016","unstructured":"Ramanujam D, Sassi Y, Laggerbauer B, Engelhardt S. Viral vector-based targeting of miR-21 in cardiac nonmyocyte cells reduces pathologic remodeling of the heart. Mol Ther. 2016;24:1939\u201348. https:\/\/doi.org\/10.1038\/mt.2016.166.","journal-title":"Mol Ther"},{"key":"1245_CR118","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980\u20134. https:\/\/doi.org\/10.1038\/nature07511.","journal-title":"Nature"},{"key":"1245_CR119","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","volume":"30","author":"S Liu","year":"2014","unstructured":"Liu S, Li W, Xu M, Huang H, Wang J, Chen X. Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts. Can J Cardiol. 2014;30:1689\u201399. https:\/\/doi.org\/10.1016\/j.cjca.2014.07.747.","journal-title":"Can J Cardiol"},{"key":"1245_CR120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","volume":"47","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol. 2009;47:5\u201314. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.01.008.","journal-title":"J Mol Cell Cardiol"},{"key":"1245_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0767-z","author":"B Dai","year":"2018","unstructured":"Dai B, Li H, Fan J, Zhao Y, Yin Z, Nie X, et al. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovasc Diabetol. 2018. https:\/\/doi.org\/10.1186\/s12933-018-0767-z.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR122","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3389\/fonc.2019.00669","volume":"9","author":"E L\u00f3pez-Urrutia","year":"2019","unstructured":"L\u00f3pez-Urrutia E, Bustamante Montes LP, Ladr\u00f3n de Guevara Cervantes D, P\u00e9rez-Plasencia C, Campos-Parra AD. Crosstalk between long non-coding RNAs, Micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer. Front Oncol. 2019;9:669. https:\/\/doi.org\/10.3389\/fonc.2019.00669.","journal-title":"Front Oncol."},{"key":"1245_CR123","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1159\/000481843","volume":"43","author":"X Zhang","year":"2017","unstructured":"Zhang X, Pan L, Yang K, Fu Y, Liu Y, Chi J, et al. H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis, fibrosis and inflammation. Cell Physiol Biochem. 2017;43:1311\u201324. https:\/\/doi.org\/10.1159\/000481843.","journal-title":"Cell Physiol Biochem"},{"key":"1245_CR124","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2147\/DMSO.S203151","volume":"12","author":"P Jia","year":"2019","unstructured":"Jia P, Wu N, Jia D, Sun Y. Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a\/HMGB1\/TLR4\/NF-\u03baB axis. Diabetes Metab Syndr Obes. 2019;12:655\u201365. https:\/\/doi.org\/10.2147\/DMSO.S203151.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1245_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27296","author":"L Gao","year":"2019","unstructured":"Gao L, Wang X, Guo S, Xiao L, Liang C, Wang Z, et al. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy. J Cell Physiol. 2019. https:\/\/doi.org\/10.1002\/jcp.27296.","journal-title":"J Cell Physiol"},{"key":"1245_CR126","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12902","author":"M Zhu","year":"2014","unstructured":"Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, et al. lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014. https:\/\/doi.org\/10.1111\/febs.12902.","journal-title":"FEBS J"},{"key":"1245_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/srep36340","author":"X Li","year":"2016","unstructured":"Li X, Wang H, Yao B, Xu W, Chen J, Zhou X. lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep36340.","journal-title":"Sci Rep"},{"key":"1245_CR128","doi-asserted-by":"publisher","first-page":"18278","DOI":"10.1002\/jcb.29134","volume":"120","author":"M Yu","year":"2019","unstructured":"Yu M, Shan X, Liu Y, Zhu J, Cao Q, Yang F, et al. RNA-Seq analysis and functional characterization revealed lncRNA NONRATT007560.2 regulated cardiomyocytes oxidative stress and apoptosis induced by high glucose. J Cell Biochem. 2019;120:18278\u201387. https:\/\/doi.org\/10.1002\/jcb.29134.","journal-title":"J Cell Biochem."},{"key":"1245_CR129","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-019-0814-4","volume":"18","author":"S Rawal","year":"2019","unstructured":"Rawal S, Nagesh PT, Coffey S, Van Hout I, Galvin IF, Bunton RW, et al. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium. Cardiovasc Diabetol. 2019;18:13. https:\/\/doi.org\/10.1186\/s12933-019-0814-4.","journal-title":"Cardiovasc Diabetol"},{"key":"1245_CR130","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbrc.2017.08.005","volume":"491","author":"X Li","year":"2017","unstructured":"Li X, Dai Y, Yan S, Shi Y, Han B, Li J, et al. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia\/reperfusion injury following acute myocardial infarction. Biochem Biophys Res Commun. 2017;491:1026\u201333. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.005.","journal-title":"Biochem Biophys Res Commun"},{"key":"1245_CR131","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2217\/epi-2017-0024","volume":"9","author":"E Coto","year":"2017","unstructured":"Coto E, Calvo D, Reguero JR, Mor\u00eds C, Rub\u00edn JM, D\u00edaz-Corte C, et al. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT. Epigenomics. 2017;9:1049\u201357. https:\/\/doi.org\/10.2217\/epi-2017-0024.","journal-title":"Epigenomics"},{"key":"1245_CR132","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Lv J, Wang Y, Che H, Chen X, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9:1000. https:\/\/doi.org\/10.1038\/s41419-018-1029-4.","journal-title":"Cell Death Dis"},{"key":"1245_CR133","doi-asserted-by":"publisher","DOI":"10.1159\/000494576","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Wang Y, Li A, Lv J, Sun X, et al. LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy. Cell Physiol Biochem. 2018. https:\/\/doi.org\/10.1159\/000494576.","journal-title":"Cell Physiol Biochem"},{"key":"1245_CR134","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1159\/000485588","volume":"44","author":"L Gao","year":"2017","unstructured":"Gao L, Liu Y, Guo S, Yao R, Wu L, Xiao L, et al. Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction. Cell Physiol Biochem. 2017;44:1497\u2013508. https:\/\/doi.org\/10.1159\/000485588.","journal-title":"Cell Physiol Biochem"},{"key":"1245_CR135","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.3892\/etm.2018.6755","volume":"16","author":"K Qi","year":"2018","unstructured":"Qi K, Zhong J. LncRNA HOTAIR improves diabetic cardiomyopathy by increasing viability of cardiomyocytes through activation of the PI3K\/Akt pathway. Exp Ther Med. 2018;16:4817\u201323. https:\/\/doi.org\/10.3892\/etm.2018.6755.","journal-title":"Exp Ther Med"},{"key":"1245_CR136","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCRESAHA.117.305962","volume":"117","author":"Y Yang","year":"2015","unstructured":"Yang Y, Cheng H-W, Qiu Y, Dupee D, Noonan M, Lin Y-D, et al. MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ Res. 2015;117:450\u20139. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.305962.","journal-title":"Circ Res"},{"key":"1245_CR137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010;11:31\u20139. https:\/\/doi.org\/10.1007\/s11154-010-9131-7.","journal-title":"Rev Endocr Metab Disord"},{"key":"1245_CR138","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","volume":"1861","author":"I Zlobine","year":"2016","unstructured":"Zlobine I, Gopal K, Ussher JR. Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim Biophys Acta. 2016;1861:1555\u201368. https:\/\/doi.org\/10.1016\/j.bbalip.2016.02.011.","journal-title":"Biochim Biophys Acta"},{"key":"1245_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cbin.10701","volume":"41","author":"Z-H Zhao","year":"2017","unstructured":"Zhao Z-H, Hao W, Meng Q-T, Du X-B, Lei S-Q, Xia Z-Y. Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury. Cell Biol Int. 2017;41:62\u201370. https:\/\/doi.org\/10.1002\/cbin.10701.","journal-title":"Cell Biol Int"},{"key":"1245_CR140","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12576","author":"P Puthanveetil","year":"2015","unstructured":"Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med. 2015. https:\/\/doi.org\/10.1111\/jcmm.12576.","journal-title":"J Cell Mol Med"},{"key":"1245_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.02.050","author":"A Congrains","year":"2012","unstructured":"Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K, et al. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun. 2012. https:\/\/doi.org\/10.1016\/j.bbrc.2012.02.050.","journal-title":"Biochem Biophys Res Commun"},{"key":"1245_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29162","author":"W Dai","year":"2019","unstructured":"Dai W, Lee D. Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress. J Cell Biochem. 2019. https:\/\/doi.org\/10.1002\/jcb.29162.","journal-title":"J Cell Biochem"},{"key":"1245_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.088","author":"SD Rosa","year":"2017","unstructured":"Rosa SD, De Rosa S, Chiefari E, Salerno N, Ventura V, D\u2019Ascoli GL, et al. HMGA1 is a novel candidate gene for myocardial infarction susceptibility. Int J Cardiol. 2017. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.088.","journal-title":"Int J Cardiol"},{"key":"1245_CR144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41419-020-2316-4","volume":"11","author":"Q-Q Wu","year":"2020","unstructured":"Wu Q-Q, Liu C, Cai Z, Xie Q, Hu T, Duan M, et al. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition. Cell Death Dis. 2020;11:160. https:\/\/doi.org\/10.1038\/s41419-020-2316-4.","journal-title":"Cell Death Dis"},{"key":"1245_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21083014","author":"M De Martino","year":"2020","unstructured":"De Martino M, Esposito F, Pellecchia S, Cortez Cardoso Penha R, Botti G, Fusco A, et al. HMGA1-regulating microRNAs Let-7a and miR-26a are downregulated in human seminomas. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21083014.","journal-title":"Int J Mol Sci."},{"key":"1245_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1698-7","author":"L Liu","year":"2019","unstructured":"Liu L, Shi Y, Shi J, Wang H, Sheng Y, Jiang Q, et al. The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. Cell Death Dis. 2019. https:\/\/doi.org\/10.1038\/s41419-019-1698-7.","journal-title":"Cell Death Dis"},{"key":"1245_CR147","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1002\/jcb.26705","volume":"119","author":"L Zhang","year":"2018","unstructured":"Zhang L, Luo X, Chen F, Yuan W, Xiao X, Zhang X, et al. LncRNA SNHG1 regulates cerebrovascular pathologies as a competing endogenous RNA through HIF-1\u03b1\/VEGF signaling in ischemic stroke. J Cell Biochem. 2018;119:5460\u201372. https:\/\/doi.org\/10.1002\/jcb.26705.","journal-title":"J Cell Biochem"},{"key":"1245_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11298","author":"S Yan","year":"2020","unstructured":"Yan S, Li H, Shu Q, Wu W, Luo X, Lu L. LncRNA SNHG1 exerts a protective role in cardiomyocytes hypertrophy via targeting miR-15a-5p\/HMGA1 axis. Cell Biol Int. 2020. https:\/\/doi.org\/10.1002\/cbin.11298.","journal-title":"Cell Biol Int"},{"key":"1245_CR149","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.2147\/OTT.S231846","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang J, Lv B, Su Y, Wang X, Bu J, Yao L. Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1\/miR-218 Axis. OncoTargets Ther. 2019;12:11325\u201338. https:\/\/doi.org\/10.2147\/OTT.S231846.","journal-title":"OncoTargets Ther"},{"key":"1245_CR150","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2018.180921","author":"Q Kong","year":"2019","unstructured":"Kong Q, Guo X, Guo Z, Su T. Urinary exosome miR-424 and miR-218 as biomarkers for Type 1 diabetes in children. Clin Lab. 2019. https:\/\/doi.org\/10.7754\/Clin.Lab.2018.180921.","journal-title":"Clin Lab."},{"key":"1245_CR151","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/0886022X.2020.1762647","volume":"42","author":"Y-L Zhang","year":"2020","unstructured":"Zhang Y-L, Wang J-M, Yin H, Wang S-B, He C-L, Liu J. DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose. Ren Fail. 2020;42:463\u201373. https:\/\/doi.org\/10.1080\/0886022X.2020.1762647.","journal-title":"Ren Fail"},{"key":"1245_CR152","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.gene.2018.08.037","volume":"678","author":"Y Lin","year":"2018","unstructured":"Lin Y, Li J, Ye S, Chen J, Zhang Y, Wang L, et al. LncRNA GACAT3 acts as a competing endogenous RNA of HMGA1 and alleviates cucurbitacin B-induced apoptosis of gastric cancer cells. Gene. 2018;678:164\u201371. https:\/\/doi.org\/10.1016\/j.gene.2018.08.037.","journal-title":"Gene"},{"key":"1245_CR153","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-3-319-42059-2_12","volume":"937","author":"H Ling","year":"2016","unstructured":"Ling H. Non-coding RNAs: therapeutic strategies and delivery systems. Adv Exp Med Biol. 2016;937:229\u201337. https:\/\/doi.org\/10.1007\/978-3-319-42059-2_12.","journal-title":"Adv Exp Med Biol"},{"key":"1245_CR154","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","volume":"126","author":"C-K Huang","year":"2020","unstructured":"Huang C-K, Kafert-Kasting S, Thum T. Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease. Circ Res. 2020;126:663\u201378. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315856.","journal-title":"Circ Res"},{"key":"1245_CR155","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20170079","author":"O Slaby","year":"2017","unstructured":"Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochem J. 2017. https:\/\/doi.org\/10.1042\/bcj20170079.","journal-title":"Biochem J"},{"key":"1245_CR156","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","volume":"376","author":"KK Ray","year":"2017","unstructured":"Ray KK, Landmesser U, Leiter LA, Kallend D, Dufour R, Karakas M, et al. Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol. N Engl J Med. 2017;376:1430\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1615758.","journal-title":"N Engl J Med"},{"key":"1245_CR157","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.118.034710","volume":"138","author":"KK Ray","year":"2018","unstructured":"Ray KK, Stoekenbroek RM, Kallend D, Leiter LA, Landmesser U, Wright RS, et al. Effect of an siRNA therapeutic targeting PCSK9 on atherogenic lipoproteins: prespecified secondary end points in ORION 1. Circulation. 2018;138:1304\u201316. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034710.","journal-title":"Circulation"},{"key":"1245_CR158","doi-asserted-by":"publisher","first-page":"e000946","DOI":"10.1161\/JAHA.114.000946","volume":"3","author":"N Bellera","year":"2014","unstructured":"Bellera N, Barba I, Rodriguez-Sinovas A, Ferret E, As\u00edn MA, Gonzalez-Alujas MT, et al. Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling. J Am Heart Assoc. 2014;3:e000946. https:\/\/doi.org\/10.1161\/JAHA.114.000946.","journal-title":"J Am Heart Assoc"},{"key":"1245_CR159","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020;4:69\u201383. https:\/\/doi.org\/10.1038\/s41551-019-0485-1.","journal-title":"Nat Biomed Eng"},{"key":"1245_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa071","author":"L Braga","year":"2020","unstructured":"Braga L, Ali H, Secco I, Giacca M. Non-coding RNA therapeutics for cardiac regeneration. Cardiovasc Res. 2020. https:\/\/doi.org\/10.1093\/cvr\/cvaa071.","journal-title":"Cardiovasc Res"},{"key":"1245_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120249","author":"C Eyileten","year":"2018","unstructured":"Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, et al. MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke-a comprehensive review and bioinformatic analysis. Cells. 2018. https:\/\/doi.org\/10.3390\/cells7120249.","journal-title":"Cells"},{"key":"1245_CR162","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","volume":"8","author":"S Alivernini","year":"2017","unstructured":"Alivernini S, Gremese E, McSharry C, Tolusso B, Ferraccioli G, McInnes IB, et al. MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis. Front Immunol. 2017;8:1932. https:\/\/doi.org\/10.3389\/fimmu.2017.01932.","journal-title":"Front Immunol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-021-01245-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01245-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:05:42Z","timestamp":1614420342000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01245-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01245-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no conflict of interest related to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}